Become a Member

written by reader A +229% biotech

By kmoffitt6, June 10, 2014

So many biotechs, so little time. A biotech, IDIX, gained 229% today on news that Merck will be buying this company that is developing a hepatitis C drug. It always amazes me when I see this happen to a stock that I haven’t seen teased! Hindsight highlights the good, bad, and envious:-)

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
34
0
Would love your thoughts, please comment.x
()
x